CPI is a non-profit 501c3 founded and run exclusively on a volunteer basis. CPI coordinates access to medical care and information relating to the treatment of COVID-19. We have gained national and international recognition for our efforts to help save lives by facilitating plasma donations. CPI has partnered with Operation Warp Speed to further antibody treatments.
Nationally Available Supply of Convalescent Plasma
If you are a blood center located outside the NY metro area, and are in need of convalescent plasma, plasma is immediately available at our partner, New York Blood Center, and can be directly ordered and shipped within hours on a non-contractual basis.
NYBC's direct contact for this is:
If you are a healthcare provider or hospital, and are in need of convalescent plasma to treat your patients, plasma is immediately available at our partner blood center, the American Red Cross. Orders will be shipped via overnight FedEx on a non-contractual basis.
Visit here for details on ordering: arc.bloodhub.com
Visit here for details on ARC's Convalescent Plasma Program
Please email us at with any issues.
Outpatient COVID-19 Antibody Treatment Now Available
(New York, NY, December 1, 2020) Covid Plasma Initiative's lifesaving efforts have expanded to include the facilitation of a newly available, potentially life-saving treatment. Referred to as monoclonal antibodies, it is an infusion of lab manufactured, concentrated antibodies, similar to those in convalescent plasma. This is the same treatment given to President Trump; and now, as of last week, it is available to the public.
Dr. Yosef Levenbrown is a Pediatric Critical Care Medicine Specialist at Dupont Hospital and the Medical Director of CPI (Advisory Board). He explains that the data from this double-blind randomized control trial indicate that monoclonal antibodies can, potentially, reduce hospitalization significantly and decrease symptom severity. Dr. Jeffrey Bander of Mt. Sinai Hospital states, "We've seen great efficacy with these drugs. As the sole outpatient treatment, monoclonal antibodies have the potential to prevent an otherwise at-risk patient from being hospitalized and keep beds available for the critically ill."
"It's a miracle drug," shares Mr. Yehudah Serle, who recently tested positive for Covid-19 and received monoclonal antibodies. "One day I wasn't feeling good. I got the treatment and the next day, B'chasdei Hashem, I was feeling much better."
Monoclonal antibody treatment can be accessed by anyone who tests positive (via PCR test, NOT rapid) and is considered 'at risk'. A person is defined as 'at risk' if they have one of the following factors: diabetes, obesity, immunosuppressed, over 65, and over 55 with hypertension. Other factors may qualify as well.
The FDA advises that monoclonal antibody treatment start as soon as possible after a positive test, preferably within 24 hours and no later than 10 days after symptom onset. It is therefore imperative to take a COVID-19 test right away if you have symptoms or were exposed. Contact your doctor immediately to discuss whether this treatment is appropriate for you and if so, to arrange access.
Hospitals providing monoclonal antibodies include Mt. Sinai (NYC), Maimonides (Brooklyn), Northwell (LI and SI), Good Samaritan (Rockland), Monmouth Medical Center Southern Campus (NJ). (Please note that not all hospitals on this list are similarly recommended for COVID-19 inpatient care).
IMPORTANT REMINDERS: COVID-19 can cause "silent hypoxia", an undetected drop in oxygen levels. A pulse oximeter is simple to use and identifies low oxygen levels before they become dangerous. Consult with a medical professional if levels drop below 95.
If you need to be hospitalized do not 'wait and see'. Choose a hospital with up-to-date treatments: plasma, steroids, blood thinners, etc. CPI currently recommends Mt. Sinai Hospital.